Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03333 |
| Species: | Homo sapiens |
| Position : | chr20:54107388-54107945 |
| Year: | 2025 |
| Title: | Drug-induced cis-regulatory elements in human hepatocytes affect molecular phenotypes associated with adverse reactions. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | glioblastoma |
| PMID: | 40301309 |
| MONDO: | MONDO:0018177 |
| Tissue: | brain |
| Tissue Ontology ID: | UBERON:0000955 |
| Cell Source: | D-566MG |
| CVCL ID: | CVCL_1166 |
| Cell Type: | glioblastoma cell |
| Cell Ontology ID: | CL:0001063 |
| Experiment Type: | Super-enhancer activity assay |
| High Throughput Method: | CAGE |
| Low Throughput Method: | Luciferase reporter assay |
| Target gene : | CYP24A1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|